Effects of recombinant insulin-like growth factor I on IGF binding proteins and the acid-labile subunit in growth hormone insensitivity syndrome.
Walker
J L
JL
Prince of Wales Children's Hospital, Sydney, Australia.
Baxter
R C
RC
Young
S
S
Pucilowska
J
J
Clemmons
D R
DR
Underwood
L E
LE
D001786:Blood Glucose / Q000378:metabolism; D002352:Carrier Proteins / Q000097:blood*; D002648:Child; D004392:Dwarfism / Q000097:blood / Q000188:drug therapy*; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D018970:Insulin-Like Growth Factor Binding Protein 1; D018971:Insulin-Like Growth Factor Binding Protein 2; D018969:Insulin-Like Growth Factor Binding Proteins; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D007335:Insulin-Like Growth Factor II / Q000378:metabolism; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
D001786:Blood Glucose; D002352:Carrier Proteins; D006023:Glycoproteins; D007328:Insulin; D018970:Insulin-Like Growth Factor Binding Protein 1; D018971:Insulin-Like Growth Factor Binding Protein 2; D018969:Insulin-Like Growth Factor Binding Proteins; D011994:Recombinant Proteins; C075944:insulin-like growth factor binding protein, acid labile subunit; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II